End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.75 CNY | +0.88% | -2.69% | -15.80% |
Business Summary
Number of employees: 931
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Agent
56.6
%
| 388 | 49.5 % | 430 | 56.6 % | +10.97% |
Pharmaceutical Manufacturing
42.7
%
| 361 | 46.1 % | 325 | 42.7 % | -9.93% |
Medical Technology Services
0.6
%
| 34 | 4.4 % | 5 | 0.6 % | -86.08% |
Other
0.1
%
| 1 | 0.1 % | 1 | 0.1 % | +4.59% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 783 | 100.0 % | 761 | 100.0 % | -2.88% |
Abroad
0.0
%
| 0 | 0.0 % | 0 | 0.0 % | -87.60% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Han Jie Zheng
CEO | Chief Executive Officer | 61 | 31/12/98 |
Gui Xi Zhou
DFI | Director of Finance/CFO | 37 | 01/12/22 |
Ting Li
BRD | Director/Board Member | 41 | 30/11/19 |
Chun Chen
BRD | Director/Board Member | 61 | 31/12/99 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ying Liang
BRD | Director/Board Member | 52 | 29/06/22 |
Yi Ping Rui
BRD | Director/Board Member | 70 | 02/02/18 |
Han Jie Zheng
CEO | Chief Executive Officer | 61 | 31/12/98 |
Wei Wen Sun
BRD | Director/Board Member | 57 | 31/12/98 |
Chun Chen
BRD | Director/Board Member | 61 | 31/12/99 |
Ting Li
BRD | Director/Board Member | 41 | 30/11/19 |
Zhi Wei Fang
BRD | Director/Board Member | 52 | 02/02/18 |
Mu Qiang Zheng
BRD | Director/Board Member | 43 | 22/07/20 |
Zi Li Lin
CHM | Chairman | 48 | 30/06/00 |
Jian Xin Wang
BRD | Director/Board Member | 46 | 31/12/98 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 425,497,500 | 189,855,917 ( 44.62 %) | 1,985,118 ( 0.4665 %) | 44.62 % |
Company contact information
Guangdong Taienkang Pharmaceutical Co., Ltd.
Block A, 8 Wanji South 2nd Street Taishan North Road
515041, Shantou
+
http://www.tai-kang.com.cnSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.80% | 804M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 301263 Stock
- Company Guangdong Taienkang Pharmaceutical Co., Ltd.